Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 May;35(5):1284-91.
doi: 10.1161/ATVBAHA.114.305200. Epub 2015 Mar 5.

Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the Framingham heart study

Affiliations

Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the Framingham heart study

Michelle T Long et al. Arterioscler Thromb Vasc Biol. 2015 May.

Abstract

Objective: Patients with nonalcoholic fatty liver disease (NAFLD) have an increased risk of cardiovascular disease; however, it is not known whether NAFLD contributes to cardiovascular disease independent of established risk factors. We examined the association between NAFLD and vascular function.

Approach and results: We conducted a cross-sectional study of 2284 Framingham Heart Study participants without overt cardiovascular disease who had liver fat attenuation measured on computed tomography and who had measurements of vascular function and covariates. We evaluated the association between NAFLD and vascular function using multivariable partial correlations adjusting for age, sex, cohort, smoking, diabetes mellitus, hyperlipidemia, hypertension, body mass index, and visceral adipose tissue. The prevalence of NAFLD in our sample (mean age, 52±12 years; 51.4% women) was 15.3%. In age-, sex-, and cohort-adjusted analyses, greater liver fat was modestly associated with lower flow-mediated dilation (r=-0.05; P=0.02), lower peripheral arterial tonometry ratio (r=-0.20; P<0.0001), higher carotid-femoral pulse wave velocity (r=0.13; P<0.0001), and higher mean arterial pressure (r=0.11; P<0.0001). In multivariable-adjusted models, NAFLD remained associated with higher mean arterial pressure (r=0.06; P=0.005) and lower peripheral arterial tonometry ratio (r=-0.12; P<0.0001). The association between NAFLD and peripheral arterial tonometry ratio persisted after further adjustment for body mass index and visceral adipose tissue.

Conclusions: For multiple measures of vascular function, the relationship with NAFLD appeared largely determined by shared cardiometabolic risk factors. The persistent relationship with reduced peripheral arterial tonometry response beyond established risk factors suggests that NAFLD may contribute to microvascular dysfunction.

Keywords: multidetector computed tomography; obesity; risk factors; vascular endothelium.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Bar chart depicting the multivariable adjusted least square means of peripheral arterial tone (PAT) ratio + standard error (SE) overall and by Body Mass Index (BMI) categories according to presence or absence of NAFLD
The BMI categories are defined as normal BMI (BMI < 25 kg/m2), Overweight (25 kg/m2 ≤ BMI < 30 kg/m2) and Obese (BMI ≥ 30 kg/m2). No NAFLD represents a normal Liver Phantom Ratio (LPR) (LPR > 0.33) and NAFLD represents an abnormal LPR (LPR ≤ 0.33). Overall, PAT ratio NAFLD vs non-NAFLD p<0.0001;PAT ratio normal weight NAFLD vs non-NAFLD p=0.26; PAT ratio overweight NAFLD vs non-NAFLD p=0.0006; PAT ratio obese NAFLD vs non-NAFLD p=0.06.

References

    1. Younossi ZM, Stepanova M, Afendy M, Fang Y, Younossi Y, Mir H, Srishord M. Changes in the prevalence of the most common causes of chronic liver diseases in the united states from 1988 to 2008. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2011;9:524–530. e521. quiz e560. - PubMed
    1. Vernon G, Baranova A, Younossi ZM. Systematic review: The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Alimentary pharmacology & therapeutics. 2011;34:274–285. - PubMed
    1. Stranges S, Trevisan M, Dorn JM, Dmochowski J, Donahue RP. Body fat distribution, liver enzymes, and risk of hypertension: Evidence from the western new york study. Hypertension. 2005;46:1186–1193. - PMC - PubMed
    1. Speliotes EK, Massaro JM, Hoffmann U, Vasan RS, Meigs JB, Sahani DV, Hirschhorn JN, O’Donnell CJ, Fox CS. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: The framingham heart study. Hepatology. 2010;51:1979–1987. - PMC - PubMed
    1. Arase Y, Suzuki F, Ikeda K, Kumada H, Tsuji H, Kobayashi T. Multivariate analysis of risk factors for the development of type 2 diabetes in nonalcoholic fatty liver disease. Journal of gastroenterology. 2009;44:1064–1070. - PubMed

Publication types

MeSH terms